期刊文献+

CT和MRI确定鼻咽癌原发肿瘤靶区的比较 被引量:10

The Comparion between the Diagnosis Value of CT and of MRI for Delineating Gross Target Volume of Nasopharyngeal Carcinoma
在线阅读 下载PDF
导出
摘要 目的:探讨鼻咽癌放疗计划设计中CT和MRI确定肿瘤靶区(GTV)的价值比较。方法:分析经病理证实的39例NPC患者的影像学资料。CT扫描采用GELightspeed型16层螺旋CT机,常规轴位平扫。MRI检查使用GESigna1.5Tesla超导磁共振成像系统。统计方法为配对t检验。结果:MRI组和CT组勾画的靶区中,肿瘤平均体积分别为(32.49±19.91)cm3,(29.06±18.75)cm3,两组对比具有显著性差异(t=5.268,P=0.000)。早期和进展期两组对比有显著性差异(t=5.677,P=0.000;t=3.310,P=0.005)。在T1、T2、T3期中两组对比差异明显(P值分别为0.005、0.001和0.004),而在T4期中两组对比无统计学意义(P=0.146)。结论:MRI组勾画靶区较CT组精确。因此建议在鼻咽癌肿瘤靶区勾画中应以MRI较为适合。 Objective: To study the accuracy between CT and MRI in delineating gross tumor volume (GRIN) of nasopharyngeal carcinoma (NPC) when making radiotherapy plan. Methods: Thirty-nine cases with nasopharyngeal carcinoma confirmed by pathology, selected during the period from April 2003 to April 2004, were reviewed retrospectively. CT scanning was performed with GE Light speed 16, routine axial scan was parallel to the OM line from soft palate to the suprasellar cistern. MR scanning was performed by GE Signa super-conducting magnetic resonance imaging system (1.5 Tesla). All data were analyzed using the paired-samples t test. Results: The mean primary tumor volume (cm3) of CT Group and MR Group were 32.49±19.91 and 29.06±18.75 respectively, and the difference between the two groups was significant (t=5.268, P=0.000). There were significant differences in the two groups at early stage and advanced stage by Fuzhou Staging System (t=5.677,P=0.000; t=3.310,P=O.O05, respectively). There was significant difference in Stage T1, T2, T3 (P=0.005, P=0.001, P=0.004, respectively), but not in stage T4 (P=0.146). Conclusion: MR is more accurate than CT in delineating GTV of NPC, so it is more valuable in making radiotherapy plan.
作者 胡国清 唐曦
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2005年第16期906-909,共4页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金资助(编号:30470525)
关键词 鼻咽肿瘤 体层摄影术 X线计算机 磁共振成像 肿瘤靶区 Nasopharyngeal carcinoma Tomography X-ray Computed Magnetic resonance imaging Gross tumor volume
作者简介 通讯作者:胡国清gqhu@tjh.tjmu.edu.cn
  • 相关文献

参考文献19

  • 1Chang CC, Chen MK, Liu MT, et al. Effect of primary tumour volumes in early T-stage Nasopharyngeal Carcinoma [J]. J Otolaryngol, 2003, 32(2):87~92.
  • 2吴开良,蒋国梁,王鹏,周莉均.肺癌三维适形放射治疗靶体积确定的影响因素[J].中华放射肿瘤学杂志,2003,12(3):188-191. 被引量:36
  • 3崔晓利,王佩国,姜之馨,肖建宇,王金妹.应用CT与MRI确定原发灶体积的局限性[J].中华放射肿瘤学杂志,2002,11(4):267-268. 被引量:3
  • 4Beatrice S, Margaret B, Jane W, et al. Target volume definition in conformal radiotherapy for prostate cancer: quality assurance in the MRC RT-01 trial[J]. Radiother Oncol, 2000, 56(1):73~83.
  • 5Chang CC, Chen MK, Wu HK, et al. Nasopharyngeal carcinoma volume measurements determined with computer tomography:study of intraobserver and interobserver variability[J]. J Otolaryngol, 2002, 31(6):361~365.
  • 6Emami B, Sethi A, Petruzzelli GJ. Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma[J]. Int J Radiat Oncol Biol Phys, 2003, 57 (2):481~488.
  • 7Parker CC, Damyanovich A, Haycocks T, et al. Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration [J]. Radiother Oncol, 2003, 66(2):217~224.
  • 8Coen R,Ronald K, Frank A, et al. The potential impact of CTMRI matching on tumor volume delineation in advanced head and neck cancer [J]. Int J Radiat Oncol Biol Phys, 1997, 39(4):841~848.
  • 9Chung NN, Ting LL, Hsu WC, et al. Impact of magnetic resonance imaging versus CT on nasopharyngeal carcinoma: primary tumor target delineation for radiotherapy[J]. Head Neck, 2004, 26(3):241~246.
  • 10Scheib S, Gianolini S, Haller D, et al. VOLUMESERIES: a software tool for target volume follow-up studies with computerized tomography and magnetic resonance imaging. Technical note[J]. J Neurosurg, 2000, 93 (Suppl 3):203~207.

二级参考文献25

  • 1洪应中.肺野[A].见:荣独山主编.X线诊断学:第2版[C].上海:上海科学技术出版社,1993.37-38.
  • 2Seddon B, Bidmead M, Wilson J, et al. Target volmne definition in confonnal radiotherapy for prostate cancer: quality asaumace in the MRC RT-01 trial. Radiother Oncol,2000,56:73-83.
  • 3lnternational Commission on Radiation Units and Measurements.Prescribing, recording, and reporting photon beam therapy(Supplement to ICRU Report 50) ,ICRU Report,62.Bethesda:ICRU ,2000.
  • 4Harris K, Adams H, Lloyd D, et al. The effect on apparent size of simulated pulmmonary nodules of using three standard CT window setting. Clin Radiol,1993,47:421.
  • 5Musset D,Grenier P,Carrette M,et al.Primary lung cancer staging:prospective comparative study of MR imaging with CT. Radiology, 1986,11:160-167.
  • 6Lynch D. Radiology staging in lung cencer . Lung Grocer, 1997, 18 Suppl 2:98-99.
  • 7Beatrice S, Margaret B, Jane W, et al. Target volmne definition in conformal radiotherapy for prostate cancer: quality assurance in the MRC RT-01 trial. Radiother Oncol, 2000,56:73-83.
  • 8Giraud P, Antoine M, Larrouy A, et al. Evaluation of microscopic tumor extension in non-retail-cell lung cancer for three-dimensional conformal radioation therapy planning, lnt J Radial Oneol Biol Phys ,2000 ,48:1015-1024.
  • 9Rosenzweig KE, Sire S,Mychalclczak B,et al. Elective nodal irradiation in treament of non-small cell lung cancer with lhree-dimemional conformal radiation therapy(3D-CRF). Int J Radiat Oncol Biol Phys,1999,45(1 Suppl 3):243-244.
  • 10International Conanission d Radiation Units and Measurements.Prescribing, recordlng and reporting photon beam therapy, report No50.Bethesda: ICRU, 1993.

共引文献39

同被引文献92

引证文献10

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部